1. Home
  2. CYBN
  3. CYBN News

Latest Cybin Inc. (CYBN) News on January 19, 2025

Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder
CYBN

Business Wire

4 days ago

Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025
CYBN

Business Wire

6 days ago

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
CYBN

Business Wire

10 days ago

Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results
CYBN

Business Wire

a month ago

Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results

Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024
CYBN

Business Wire

2 months ago

Cybin to Participate in Water Tower Research Fireside Chat on December 11, 2024

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder
CYBN

Business Wire

2 months ago

Cybin Reports Positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024
CYBN

Business Wire

2 months ago

Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results
CYBN

Business Wire

2 months ago

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results

Cybin to Participate at the 2024 Milken Institute Future of Health Summit
CYBN

Business Wire

3 months ago

Cybin to Participate at the 2024 Milken Institute Future of Health Summit

Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program
CYBN

Business Wire

3 months ago

Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program

Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
CYBN

Business Wire

4 months ago

Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024

Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
CYBN

Business Wire

4 months ago

Cybin Expands Clinical Team to Support CYB003 Phase 3 Program

Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
CYBN

Business Wire

4 months ago

Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit

Cybin Provides Corporate Update on Upcoming Clinical Milestones
CYBN

Business Wire

4 months ago

Cybin Provides Corporate Update on Upcoming Clinical Milestones

Cybin Announces Completion of Previously Announced Share Consolidation
CYBN

Business Wire

4 months ago

Cybin Announces Completion of Previously Announced Share Consolidation

Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
CYBN

Business Wire

4 months ago

Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation
CYBN

Business Wire

5 months ago

Cybin Announces Results of Annual and Special Meeting of Shareholders and Share Consolidation

Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder
CYBN

Business Wire

5 months ago

Cybin Announces Completion of FDA Type B Initial Breakthrough Therapy Meeting and Plans for CYB003 Phase 3 Program in Major Depressive Disorder

Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
CYBN

Business Wire

5 months ago

Cybin Reports First Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference
CYBN

Business Wire

5 months ago

Cybin to Participate in the Canaccord Genuity 44th Annual Growth Conference

A Swell Of Insider Purchases Follow Cybin Inc.'s Positive Year-End Update
CYBN

Newsfile

6 months ago

A Swell Of Insider Purchases Follow Cybin Inc.'s Positive Year-End Update

What Makes Cybin Inc. (CYBN) a New Buy Stock
CYBN

Zacks

7 months ago

What Makes Cybin Inc. (CYBN) a New Buy Stock

Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
CYBN

Business Wire

7 months ago

Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights

Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
CYBN

Business Wire

7 months ago

Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround
CYBN

Zacks

7 months ago

Down -17.45% in 4 Weeks, Here's Why Cybin Inc. (CYBN) Looks Ripe for a Turnaround

Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
CYBN

Business Wire

7 months ago

Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development

Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
CYBN

Business Wire

8 months ago

Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024

Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
CYBN

Business Wire

8 months ago

Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase

Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
CYBN

Business Wire

8 months ago

Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones

Cybin to Participate at the 27th Annual Milken Institute Global Conference
CYBN

Business Wire

9 months ago

Cybin to Participate at the 27th Annual Milken Institute Global Conference

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
CYBN

Business Wire

9 months ago

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
CYBN

Business Wire

9 months ago

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder

Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
CYBN

Business Wire

9 months ago

Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million
CYBN

Business Wire

10 months ago

Cybin Announces Closing of the Oversubscribed Private Placement of U.S. $150 Million

Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
CYBN

Business Wire

10 months ago

Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas

Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder
CYBN

Business Wire

10 months ago

Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder

Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
CYBN

Business Wire

10 months ago

Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design

Announces Oversubscribed Private Placement of U.S. $150 Million
CYBN

Business Wire

10 months ago

Announces Oversubscribed Private Placement of U.S. $150 Million

Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder
CYBN

Business Wire

10 months ago

Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder

Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003
CYBN

Business Wire

10 months ago

Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003

Cybin to Present at the TD Cowen 44th Annual Health Care Conference
CYBN

Business Wire

a year ago

Cybin to Present at the TD Cowen 44th Annual Health Care Conference

Cybin Reports Third Quarter Financial Results and Recent Business Highlights
CYBN

Business Wire

a year ago

Cybin Reports Third Quarter Financial Results and Recent Business Highlights

Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
CYBN

Business Wire

a year ago

Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program

Why Domo (DOMO) Shares Are Getting Obliterated Today
CYBN

StockStory

a year ago

Why Domo (DOMO) Shares Are Getting Obliterated Today

CYBN

Business Wire

a year ago

Putnam Investments Announces Distribution Rates for Closed-End Funds

CYBN

Market Exclusive

a year ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?
CYBN

Simply Wall St.

a year ago

Is LSI Industries Inc. (NASDAQ:LYTS) Trading At A 44% Discount?

Immersion Corporation (IMMR) Is a Trending Stock: Facts to Know Before Betting on It
CYBN

Zacks

a year ago

Immersion Corporation (IMMR) Is a Trending Stock: Facts to Know Before Betting on It

Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
CYBN

Business Wire

a year ago

Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder

CYBN

GuruFocus.com

a year ago

Home Bancorp Inc (HBCP) Reports Q4 Earnings, Declares Dividend Amidst Economic Challenges

Home Bancorp (HBCP) Reports Q4 Earnings: What Key Metrics Have to Say
CYBN

Zacks

a year ago

Home Bancorp (HBCP) Reports Q4 Earnings: What Key Metrics Have to Say

Sinclair Announces Annual Diversity Scholarship Submission for 2024, Shaping the Future of Broadcasting
CYBN

Business Wire

a year ago

Sinclair Announces Annual Diversity Scholarship Submission for 2024, Shaping the Future of Broadcasting

CYBN

Business Wire

a year ago

Putnam Investments Announces 19(a) Notices for Closed-End Municipal Funds

Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results
CYBN

Zacks

a year ago

Amarin (AMRN) Stock Rises on Stellar Q4 Preliminary Results

CYBN

Business Wire

a year ago

Luxfer Declares Quarterly Dividend

CYBN

Business Wire

a year ago

Franklin Limited Duration Income Trust ("FTF" or the "Fund") Announces Distribution

AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss
CYBN

Zacks

a year ago

AngioDynamics (ANGO) Q2 Earnings Top Estimates, Revenues Miss

Rigel Pharmaceuticals Provides Business Update
CYBN

PR Newswire

a year ago

Rigel Pharmaceuticals Provides Business Update

Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028
CYBN

Business Wire

a year ago

Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028

National Bank Holdings Corporation Announces Date for 2023 Fourth Quarter Earnings Release
CYBN

GlobeNewswire

a year ago

National Bank Holdings Corporation Announces Date for 2023 Fourth Quarter Earnings Release

Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
CYBN

Business Wire

a year ago

Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs

Is Now An Opportune Moment To Examine Luxfer Holdings PLC (NYSE:LXFR)?
CYBN

Simply Wall St.

a year ago

Is Now An Opportune Moment To Examine Luxfer Holdings PLC (NYSE:LXFR)?

Insider Sell: President and CEO Bailey John E. (Jack) Jr. Sells 32,983 Shares of G1 Therapeutics Inc
CYBN

GuruFocus.com

a year ago

Insider Sell: President and CEO Bailey John E. (Jack) Jr. Sells 32,983 Shares of G1 Therapeutics Inc

Nano Dimension Announces Record Fourth Quarter and Full Year 2023 Preliminary Results
CYBN

GlobeNewswire

a year ago

Nano Dimension Announces Record Fourth Quarter and Full Year 2023 Preliminary Results

Highland Global Allocation Fund Declares Monthly Distributions of $0.081 Per Share
CYBN

PR Newswire

a year ago

Highland Global Allocation Fund Declares Monthly Distributions of $0.081 Per Share

‘Time to Hit Buy,’ Says Jefferies About These 2 Timeshare Stocks
CYBN

TipRanks

a year ago

‘Time to Hit Buy,’ Says Jefferies About These 2 Timeshare Stocks

All You Need to Know About LINKBANCORP, Inc. (LNKB) Rating Upgrade to Strong Buy
CYBN

Zacks

a year ago

All You Need to Know About LINKBANCORP, Inc. (LNKB) Rating Upgrade to Strong Buy

CYBN

Business Wire

a year ago

Franklin Limited Duration Income Trust ("FTF" or the "Fund") Announces Notification of Sources of Distributions

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans
CYBN

GlobeNewswire

a year ago

TeraWulf Reports Fully Funded 7.9 EH/s and Future Expansion Plans

NaaS Won the "Best Listed Company at ESG Information Disclosure"
CYBN

PR Newswire

a year ago

NaaS Won the "Best Listed Company at ESG Information Disclosure"

CYBN

Business Wire

a year ago

Franklin Limited Duration Income Trust ("FTF") Announces Change to Managed Distribution Plan

First Mid Bancshares (FMBH) Stock Jumps 5.8%: Will It Continue to Soar?
CYBN

Zacks

a year ago

First Mid Bancshares (FMBH) Stock Jumps 5.8%: Will It Continue to Soar?

Thirty-One Members of Congress Call Upon Pentagon to Develop Plan for Processing Deep-Sea Polymetallic Nodules
CYBN

GlobeNewswire

a year ago

Thirty-One Members of Congress Call Upon Pentagon to Develop Plan for Processing Deep-Sea Polymetallic Nodules

Calculating The Fair Value Of FutureFuel Corp. (NYSE:FF)
CYBN

Simply Wall St.

a year ago

Calculating The Fair Value Of FutureFuel Corp. (NYSE:FF)

CYBN

GuruFocus.com

a year ago

Star Group LP (SGU) Faces Decline in Q4 Revenue Amid Market Volatility

Star Group, L.P. Reports Fiscal 2023 Fourth Quarter Results
CYBN

GlobeNewswire

a year ago

Star Group, L.P. Reports Fiscal 2023 Fourth Quarter Results

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program
CYBN

Business Wire

a year ago

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program

Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results
CYBN

Business Wire

a year ago

Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
CYBN

Business Wire

a year ago

Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses

CYBN

Business Wire

a year ago

L’Officiel Art and AMTD IDEA, in Partnership with ENVISEAM, Hosts an Exclusive VIP Event to Celebrate the Successful Collaboration between Christie’s and Jay Chou on this Autumn’s Post- Millennium Evening Sale

L’Officiel announces the launch of L’Officiel Hong Kong
CYBN

Business Wire

a year ago

L’Officiel announces the launch of L’Officiel Hong Kong

25 Most Profitable Businesses With Least Investment in India
CYBN

Insider Monkey

a year ago

25 Most Profitable Businesses With Least Investment in India

Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City
CYBN

Business Wire

a year ago

Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City

PennantPark Investment Corporation Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2023
CYBN

GlobeNewswire

a year ago

PennantPark Investment Corporation Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2023

FutureFuel (NYSE:FF) investors are sitting on a loss of 39% if they invested five years ago
CYBN

Simply Wall St.

a year ago

FutureFuel (NYSE:FF) investors are sitting on a loss of 39% if they invested five years ago

Earnings Estimates Rising for Legacy Housing (LEGH): Will It Gain?
CYBN

Zacks

a year ago

Earnings Estimates Rising for Legacy Housing (LEGH): Will It Gain?

SoundThinking Earns “World Class” NPS Rating in 2023 Customer Loyalty Survey
CYBN

GlobeNewswire

a year ago

SoundThinking Earns “World Class” NPS Rating in 2023 Customer Loyalty Survey

Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript
CYBN

Insider Monkey

a year ago

Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript

NuScale Power Stock Tumbles After Small Nuclear Plant Cancellation
CYBN

The Wall Street Journal

a year ago

NuScale Power Stock Tumbles After Small Nuclear Plant Cancellation

B&G Foods sells Green Giant US canned vegetable line to Seneca Foods
CYBN

Food Dive

a year ago

B&G Foods sells Green Giant US canned vegetable line to Seneca Foods

CYBN

Thomson Reuters StreetEvents

a year ago

Q3 2023 Chicago Atlantic Real Estate Finance Inc Earnings Call

CYBN

GuruFocus.com

a year ago

Chicago Atlantic Real Estate Finance Inc (REFI) Reports Q3 2023 Financial Results

Chicago Atlantic Real Estate Finance Announces Third Quarter 2023 Financial Results
CYBN

GlobeNewswire

a year ago

Chicago Atlantic Real Estate Finance Announces Third Quarter 2023 Financial Results

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
CYBN

GlobeNewswire

a year ago

Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates

Share on Social Networks: